These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24693662)

  • 21. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
    Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological status for BTV-8 in French cattle prior to the 2015 re-emergence.
    Courtejoie N; Durand B; Bréard E; Sailleau C; Vitour D; Zientara S; Gorlier A; Baurier F; Gourmelen C; Benoit F; Achour H; Milard C; Poliak S; Pagneux C; Viarouge C; Zanella G
    Transbound Emerg Dis; 2018 Feb; 65(1):e173-e182. PubMed ID: 28940827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of an early warning system against bluetongue virus in Switzerland.
    Racloz V; Straver R; Kuhn M; Thur B; Vanzetti T; Stärk KD; Griot C; Cagienard A
    Schweiz Arch Tierheilkd; 2006 Nov; 148(11):593-8. PubMed ID: 17209508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination.
    Szmaragd C; Wilson AJ; Carpenter S; Wood JL; Mellor PS; Gubbins S
    PLoS One; 2010 Feb; 5(2):e9353. PubMed ID: 20179768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bluetongue virus serotype 8 (BTV-8) infection reduces fertility of Dutch dairy cattle and is vertically transmitted to offspring.
    Santman-Berends IM; Hage JJ; van Rijn PA; Stegeman JA; van Schaik G
    Theriogenology; 2010 Nov; 74(8):1377-84. PubMed ID: 20688368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Milk concentration improves Bluetongue antibody detection by use of an indirect ELISA.
    Chaignat V; Nitzsche S; Schärrer S; Feyer D; Schwermer H; Thur B
    Vet Microbiol; 2010 Jul; 143(2-4):179-83. PubMed ID: 20042301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of bluetongue in Europe.
    Zientara S; Sánchez-Vizcaíno JM
    Vet Microbiol; 2013 Jul; 165(1-2):33-7. PubMed ID: 23462519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of monthly collected milk yields for the detection of the emergence of the 2007 French BTV epizootic.
    Madouasse A; Marceau A; Lehébel A; Brouwer-Middelesch H; van Schaik G; Van der Stede Y; Fourichon C
    Prev Vet Med; 2014 Mar; 113(4):484-91. PubMed ID: 24433639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of bluetongue disease in Germany by vaccination.
    Baetza HJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):116-9. PubMed ID: 24090604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bluetongue virus in the French Island of Reunion.
    Bréard E; Sailleau C; Hamblin C; Zientara S
    Vet Microbiol; 2005 Apr; 106(3-4):157-65. PubMed ID: 15778021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bluetongue sentinel surveillance program and cross-sectional serological survey in cattle in Belgium in 2010-2011.
    Vangeel I; De Leeuw I; Méroc E; Vandenbussche F; Riocreux F; Hooyberghs J; Raemaekers M; Houdart P; Van der Stede Y; De Clercq K
    Prev Vet Med; 2012 Oct; 106(3-4):235-43. PubMed ID: 22483650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant vaccines against bluetongue virus.
    Calvo-Pinilla E; Castillo-Olivares J; Jabbar T; Ortego J; de la Poza F; Marín-López A
    Virus Res; 2014 Mar; 182():78-86. PubMed ID: 24287057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.